These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 16434898

  • 1. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
    Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP.
    Am J Surg Pathol; 2006 Feb; 30(2):230-6. PubMed ID: 16434898
    [Abstract] [Full Text] [Related]

  • 2. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.
    Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
    [Abstract] [Full Text] [Related]

  • 3. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC.
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [Abstract] [Full Text] [Related]

  • 4. Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.
    Lee YJ, Lee SW, Kim KR, Jung KH, Lee JW, Kim YM.
    J Gynecol Oncol; 2017 Jan; 28(1):e3. PubMed ID: 27670257
    [Abstract] [Full Text] [Related]

  • 5. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP.
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [Abstract] [Full Text] [Related]

  • 6. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
    Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP.
    Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760
    [Abstract] [Full Text] [Related]

  • 7. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y, Chen XD, Lü BJ, Zhou CY, Zhang XF, Shi HY.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [Abstract] [Full Text] [Related]

  • 8. Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.
    Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto MG, Crum CP.
    Adv Anat Pathol; 2006 Jan; 13(1):1-7. PubMed ID: 16462151
    [Abstract] [Full Text] [Related]

  • 9. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH, Milea A, Shaw PA.
    Clin Cancer Res; 2012 Nov 15; 18(22):6199-207. PubMed ID: 22967960
    [Abstract] [Full Text] [Related]

  • 10. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S, Tolonen T, Laasanen SL, Mecklin JP, Isola J, Mäenpää J.
    Int J Gynecol Pathol; 2014 May 15; 33(3):309-16. PubMed ID: 24681744
    [Abstract] [Full Text] [Related]

  • 11. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
    Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H.
    Mod Pathol; 2009 Sep 15; 22(9):1133-8. PubMed ID: 19543244
    [Abstract] [Full Text] [Related]

  • 12. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P, Dundr P.
    Cesk Patol; 2016 Sep 15; 52(4):199-204. PubMed ID: 27869446
    [Abstract] [Full Text] [Related]

  • 13. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J, Shi JL, Shen DH, Chen YX, Song QJ.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul 15; 41(7):433-7. PubMed ID: 22932451
    [Abstract] [Full Text] [Related]

  • 14. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
    Reitsma W, de Bock GH, Oosterwijk JC, Bart J, Hollema H, Mourits MJ.
    Eur J Cancer; 2013 Jan 15; 49(1):132-41. PubMed ID: 22921157
    [Abstract] [Full Text] [Related]

  • 15. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB, Irving J, Köbel M, Lee C, Singh N, Wilkinson N, McCluggage WG.
    Am J Surg Pathol; 2015 Mar 15; 39(3):357-64. PubMed ID: 25517954
    [Abstract] [Full Text] [Related]

  • 16. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 17. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
    Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Dec 25; 33(12):1878-85. PubMed ID: 19898224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ, Wang YY, Li Z, Wu KY, Kong LF, Zheng WX.
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug 08; 46(8):542-547. PubMed ID: 28810294
    [Abstract] [Full Text] [Related]

  • 20. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ.
    Am J Surg Pathol; 2014 Jun 08; 38(6):729-42. PubMed ID: 24820399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.